More than 11,500 people visit Australian emergency departments each year because of anaphylaxis.
The public consultation for the Guiding principles to achieve continuity in medication management is open until 11:59 AEDT Monday, 20 December 2021. A consultation paper has been developed to guide you through the proposed recommendations for updating the Guiding Principles.
The Acute Anaphylaxis Clinical Care Standard contains six quality statements and a set of indicators to improve the recognition, treatment and follow-up of anaphylaxis in acute care.
National launch and live webcast
The Acute Anaphylaxis Clinical Care Standard was launched via webcast on Wednesday, 24 November 2021.
The Australian Commission on Safety and Quality in Health Care (the Commission) is not a regulator. As such, the Guide does not directly apply to the Commission. However, some of the Commission’s activities support regulatory functions.
This guide provides the healthcare workforce with a concise overview of the incident management process and its underlying principles.
The Acute Anaphylaxis Clinical Care Standard will help to ensure that Australians receive prompt treatment to manage severe allergic reactions, and that there is continuity of patient care across healthcare settings.
This infographic outlines key data highlights on anaphylaxis in Australia, to support the release of the new standard on 24 November 2021.
An example of data used in the Antimicrobial Stewardship Clinical Care Standard Indicator Monitoring Tool.
Antimicrobial Stewardship Clinical Care Standard Indicator Monitoring Tool - template for use by Clinicians and Health Service Organisations.